See how your answers relate to your colleagues'.


The DIaMonD (Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes) trial found that:
CGM significantly decreased diabetes distress
CGM significantly enhanced hypoglycemic confidence
CGM significantly improved both diabetes distress and hypoglycemic confidence
CGM significantly improved patients' well-being
CGM significantly improved patients' health status
Submit